| Financial Year |
March 31 2023 |
| Monetary Funds |
958,625,737.53 |
| Held-for-trading Financial Assets |
241,857,609.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
121,332,936.94 |
| Advances to Suppliers |
11,191,337.95 |
| Other Receivables |
38,999,942.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,610,284.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,743,493.20 |
| Other Current Assets |
23,800,245.58 |
| Total Current Assets |
1,401,161,587.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,349,805.01 |
| Long-term Equity Investment |
133,149,713.25 |
| Investment Properties |
-- |
| Fixed Assetes |
51,735,657.64 |
| Under-construction Projects |
113,275,056.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,734,228.87 |
| R&D expenses |
-- |
| Goodwill |
13,176,687.76 |
| Long-Term Deferred and Prepaid Expenses |
103,967,773.17 |
| Deferred Income Tax Assets |
31,371,548.82 |
| Other Non-Current Assets |
299,641,479.40 |
| Sub-Total of Non-Current Assets |
1,491,055,965.77 |
| Total Assets |
2,892,217,552.80 |
| Short-Term Loans |
9,990,004.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
217,967,300.26 |
| Accounts Received In Advance |
4,664,289.51 |
| Employee Compensation Payable |
30,809,692.31 |
| Taxes Payable |
8,342,529.37 |
| Interest Payable |
927,872.89 |
| Dividend Payable |
2,225.88 |
| Other payables |
72,956,153.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
163,679,069.17 |
| Other Current Liabilities |
6,477,968.52 |
| Sub-Total of Current Liabilities |
616,527,845.62 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,358,953.56 |
| Other Non-Current Liabilities |
555,483.50 |
| Sub-Total of Non-Current Liabilities |
562,831,502.38 |
| Total Liabilities |
1,179,359,348.00 |
| Paid-In Capital(Or Share Stock) |
448,200,000.00 |
| Capital Surplus |
754,880,640.49 |
| Surplus Reserve |
126,738,878.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
64,602,245.99 |
| Minority Stockholder's Interest |
102,287,557.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,610,570,646.95 |
| Owner's Equity（Stockholder's Equity） |
1,712,858,204.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,892,217,552.80 |
